TR-002 for the Treatment of Advanced Unresectable Metastatic Solid Tumors Unresectable or Metastatic, Refractory Pancreatic Adenocarcinoma
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This phase I trial tests the safety, side effects and best dose of TR-002 for the treatment of solid tumors that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced), that cannot be removed by surgery (unresectable), that has spread from where it first started (primary site) to other places in the body (metastatic) and unresectable or metastatic pancreatic adenocarcinoma that does not respond to treatment (refractory). Chemotherapy drugs, such as TR-002, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. TR-002 may be safe and tolerable in treating patients with advanced, unresectable or metastatic solid tumors and unresectable or metastatic, refractory pancreatic adenocarcinoma.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek 18 lat lub więcej
- •Potwierdzony nowotwór stały, który rozprzestrzeniła się na inne części ciała lub nie można go usunąć chirurgicznie
- •Standardowe leczenia nie działają lub pacjent ich nie toleruje
- •Dla raka trzustki: chory na nowotwór, który nie reaguje na wszystkie standardowe leki (gemcytabina, nab-paklitaksel, fluoropirymidyny, oksaliplatyna, irynotekan)
- •Dobre funkcjonowanie serca (wynik > 50% przy badaniu serca)
- •Stan ogólny pacjenta pozwalający na leczenie (wynik ECOG 0-2)
- •Prawidłowe wyniki badań krwi (liczba neutrofili, płytki krwi, hemoglobina) i czynność nerek i wątroby
- •Chęć stosowania antykoncepcji przez osoby mogące zajść w ciążę
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 16, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
University of California Davis Comprehensive Cancer Center
Sacramento, United States
Trial contact
Office of Clinical Research
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/17/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.